AR-LDD
- Generic Name
- AR-LDD
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
Phase 3
Recruiting
- Conditions
- Metastatic Castration-resistant Prostate Cancer
- Interventions
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Celgene
- Target Recruit Count
- 960
- Registration Number
- NCT06764485
- Locations
- ๐ฎ๐ช
Local Institution - 0273, Dublin, Ireland
๐ฎ๐นLocal Institution - 0159, Terni, Italy
๐ฎ๐นLocal Institution - 0156, Arezzo, Italy
A Study to Evaluate the Drug Levels, Metabolism and Excretion, and Absolute Bioavailability of BMS-986365 in Healthy Male Participants
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- Drug: [14C] BMS-986409 + BMS-986410Drug: [14C] BMS-986410 + BMS-986409Drug: [14C] BMS-986365
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- Celgene
- Target Recruit Count
- 24
- Registration Number
- NCT06433505
- Locations
- ๐บ๐ธ
Local Institution - 0001, Madison, Wisconsin, United States
Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- Celgene
- Target Recruit Count
- 102
- Registration Number
- NCT06417229
- Locations
- ๐บ๐ธ
Local Institution - 0001, Lenexa, Kansas, United States
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer
Phase 1
Active, not recruiting
- Conditions
- Prostatic Neoplasms
- Interventions
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Celgene
- Target Recruit Count
- 250
- Registration Number
- NCT04428788
- Locations
- ๐บ๐ธ
Local Institution - 116, Stanford, California, United States
๐บ๐ธLocal Institution - 122, Washington, District of Columbia, United States
๐บ๐ธLocal Institution - 103, Sarasota, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
ยฉ Copyright 2025. All Rights Reserved by MedPath